Xingnan Pan

590 total citations
13 papers, 203 citations indexed

About

Xingnan Pan is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Xingnan Pan has authored 13 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Xingnan Pan's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease and Transplantation (3 papers). Xingnan Pan is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease and Transplantation (3 papers). Xingnan Pan collaborates with scholars based in China and United Kingdom. Xingnan Pan's co-authors include Qian Liu, Xiaoman Zhang, Ming Liu, Guohong Deng, Qian Liu, Qing Mao, Shide Lin, Jie Xia, Huifen Wang and Wenting Tan and has published in prestigious journals such as Gut, Scientific Reports and Medicine.

In The Last Decade

Xingnan Pan

12 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingnan Pan China	8	140	132	48	32	23	13	203
Yinong Ye China	9	130 0.9×	118 0.9×	36 0.8×	26 0.8×	54 2.3×	16	219
Rick Z. Li United States	3	77 0.6×	75 0.6×	24 0.5×	61 1.9×	29 1.3×	4	172
Tomomi Hakoda Japan	6	80 0.6×	119 0.9×	51 1.1×	17 0.5×	48 2.1×	7	172
Anbin Hu China	10	50 0.4×	132 1.0×	126 2.6×	56 1.8×	38 1.7×	33	254
Ahmad Karadagi Sweden	7	28 0.2×	55 0.4×	69 1.4×	63 2.0×	11 0.5×	18	156
Marina Bárcena‐Varela Spain	8	75 0.5×	85 0.6×	38 0.8×	139 4.3×	15 0.7×	11	253
Diane R. Abraczinskas United States	6	135 1.0×	139 1.1×	99 2.1×	58 1.8×	3 0.1×	10	260
Rozanne C. de Veer Netherlands	7	74 0.5×	76 0.6×	23 0.5×	148 4.6×	26 1.1×	10	278
Fukiko Kawai‐Kitahata Japan	9	199 1.4×	236 1.8×	24 0.5×	33 1.0×	17 0.7×	17	271
Daniela Purcea Switzerland	10	47 0.3×	46 0.3×	33 0.7×	87 2.7×	13 0.6×	15	244

Countries citing papers authored by Xingnan Pan

Since Specialization

Citations

This map shows the geographic impact of Xingnan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingnan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingnan Pan more than expected).

Fields of papers citing papers by Xingnan Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingnan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingnan Pan. The network helps show where Xingnan Pan may publish in the future.

Co-authorship network of co-authors of Xingnan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xingnan Pan. A scholar is included among the top collaborators of Xingnan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingnan Pan. Xingnan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chen, Yuxia, et al.. (2024). A non-invasive diagnostic nomogram for CHB-related early cirrhosis: a prospective study. Scientific Reports. 14(1). 15343–15343.

Gu, Ying, Xingnan Pan, Sha Chen, et al.. (2024). Behenic acid alleviates inflammation and insulin resistance in gestational diabetes mellitus by regulating TLR4/NF-κB signaling pathway. iScience. 27(10). 111019–111019. 2 indexed citations

Pan, Xingnan, et al.. (2019). Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT. Scientific Reports. 9(1). 1170–1170. 17 indexed citations

Pan, Xingnan, et al.. (2018). Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection. Journal of Medical Virology. 90(6). 1053–1062. 21 indexed citations

Tan, Wenting, Jie Xia, Yunjie Dan, et al.. (2017). Genome-wide association study identiﬁes HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure. Gut. 67(4). 757–766. 30 indexed citations

Chen, Xianli, et al.. (2015). Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report. Oncology Letters. 9(6). 2495–2498. 4 indexed citations

Pan, Xingnan, Xuhong Li, Xiaolong Liu, et al.. (2015). Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection. International Immunopharmacology. 27(2). 238–243. 12 indexed citations

Pan, Xingnan, et al.. (2015). Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease. Medicine. 94(12). e659–e659. 47 indexed citations

Pan, Xingnan, et al.. (2014). Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B. Molecular Medicine Reports. 11(4). 2644–2652. 17 indexed citations

10.

Pan, Xingnan. (2014). Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: A meta-analysis. World Journal of Gastroenterology. 20(38). 14051–14051. 40 indexed citations

11.

Pan, Xingnan, et al.. (2014). [Huge hepatic angiosarcoma with spine, pelvis, spleen and pulmonary metastases: a case report].. PubMed. 22(4). 311–311. 1 indexed citations

12.

Liu, Bo, et al.. (2009). [Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B].. PubMed. 17(7). 505–8. 7 indexed citations

13.

Pan, Xingnan, et al.. (2008). [Autologous bone marrow stem cell transplantation for treatment terminal liver diseases].. PubMed. 28(7). 1207–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact